🇺🇸 FDA
Patent

US 11116733

Topical dapsone and dapsone/adaplene compositions and methods for use thereof

granted A61KA61K31/136A61K31/145

Quick answer

US patent 11116733 (Topical dapsone and dapsone/adaplene compositions and methods for use thereof) held by ALMIRALL, LLC expires Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ALMIRALL, LLC
Grant date
Tue Sep 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/136, A61K31/145, A61K31/192, A61K47/10